Pfizer Inc.’s Covid-19 vaccine for children between the ages of 5 and 11 is expected to be officially available by the end of October, according to US health officials. Pfizer will provide enough data from clinical trials to the U.S. Food and Drug Administration (FDA) to allow emergency use for that age group, and then make it possible to vaccinate young children by the end of October. Health officials estimate that the FDA can make a decision on whether the vaccine is safe and effective for young children within three weeks of being notified.
Millions of Americans are eagerly awaiting vaccinations for young children. This includes especially those whose children have been infected with the delta type in recent weeks. The White House’s chief health adviser, Dr. Foucault said that if Pfizer submits its report by the end of September, Pfizer could produce by October.
Fauchi said Modernna Inc. will take more than three weeks longer than Pfizer to collect and analyze information for children aged 5-11. He predicts a decision on modern vaccines could be made around November.
In the United States, there has been a steady increase in the incidence of corona due to the delta type. In such cases, Pfizer health experts claim that the vaccine will soon be approved for children under 12 years of age. Speaking to CNBC, former Food and Drug Administration Commissioner Scott Gottlieb said he hoped the US Department of Health would soon approve the vaccine for children aged 5 to 11.
While schools have been opened in many US states, children are required to wear masks there. Infection has been on the rise among children in the United States over the past few days. Which has led to many children being hospitalized. According to the USA Center for Disease Control and Prevention (CDC), cases of corona are increasing rapidly in the northern part of the country, while the rate of infection was higher in the southern state last year.